Upadacitinib is a pharmaceutical raw material that functions as a Janus kinase inhibitor. It is used in the manufacturing of medications that modulate inflammatory processes.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Upadacitinib?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Upadacitinib
pharmaceutical raw material
Upadacitinib hemihydrate
pharmaceutical raw material
Abrocitinib
pharmaceutical raw material
Peficitinib
pharmaceutical raw material
Baricitinib
pharmaceutical raw material
N-methyl-3-pyrrolidinyl cyclopentylmandelate
pharmaceutical raw material
2-[(4,6-Dimethyl-2-pyrimidinyl)oxy]-3,3-diphenyl-2-propenoic Acid
pharmaceutical raw material
Erythromycin oxime
pharmaceutical raw material
The international HS code for Upadacitinib (CAS 1310726-60-3) is 2933.99.
2933.99
2933 99 80
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
(3S,4R)-3-ethyl-4-(1,5,7,10-tetrazatricyclo[7.3.0.02,6]dodeca-2(6),3,7,9,11-pentaen-12-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide
WYQFJHHDOKWSHR-MNOVXSKESA-N
CC[C@@H]1CN(C[C@@H]1C2=CN=C3N2C4=C(NC=C4)N=C3)C(=O)NCC(F)(F)F
Sourcing Upadacitinib?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.